Legislation aiming to reform the regulation of pharmacy benefit managers (PBMs) remains on the horizon on both the federal and state levels. In particular, 2023 was a fertile year for PBM legislative initiatives....more
5/2/2024
/ Disclosure ,
Drug Pricing ,
Employee Retirement Income Security Act (ERISA) ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Reimbursements ,
Remuneration ,
Reporting Requirements ,
Transparency
Health Care was a hot topic in the U.S. Senate on February 8, as two important Senate Committees – the Committee on Finance and the Committee on Health, Education, Labor, and Pensions (HELP) – held hearings, respectively, on...more
2/14/2024
/ Artificial Intelligence ,
Bias ,
Drug Pricing ,
Equity ,
Healthcare ,
HELP ,
Individual Accountability ,
Legislative Agendas ,
Pharmaceutical Industry ,
Prescription Drugs ,
Privacy Laws ,
Senate Finance Committee ,
Transparency